Literature DB >> 1689666

A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig.

B V Zlokovic1, D S Skundric, M B Segal, M N Lipovac, J B Mackic, H Davson.   

Abstract

The existence of an immunological blood-brain barrier to homologous blood-borne immunoglobulin G (IgG) was investigated in the guinea pig using a vascular brain perfusion technique in situ. Cerebrovascular unidirectional transfer constants (Kin) for 125I-labeled IgG (2.5 micrograms/ml) estimated from the multiple-time brain uptake data, ranged from 0.53 to 0.58 ml min-1 g-1 X 10(3) in the parietal cortex, hippocampus, and caudate nucleus, the transfer rate being some 10 times higher than that for [3H]dextran (MW 70,000). In the presence of 4 mg/ml unlabeled IgG, unidirectional blood to brain transfer of 125I-IgG was markedly inhibited. Immunohistochemical analysis of the brain tissue after vascular perfusion with unlabeled IgG revealed a distribution of the blood-borne immunoglobulin in the endothelial cells of microvessels and in the surrounding perivascular tissue. It is concluded that there is a specific transfer mechanism for IgG at the blood-brain barrier in the guinea pig, which is saturated at physiological plasma levels of IgG.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689666     DOI: 10.1016/0014-4886(90)90144-h

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  18 in total

Review 1.  The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.

Authors:  R Deane; A Sagare; B V Zlokovic
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 2.  Tau-focused immunotherapy for Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  Curr Alzheimer Res       Date:  2009-10       Impact factor: 3.498

Review 3.  Pathophysiology of the blood-brain barrier.

Authors:  K Selmaj
Journal:  Springer Semin Immunopathol       Date:  1996

Review 4.  Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier.

Authors:  B V Zlokovic
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

Review 5.  Antibody-mediated clearance of viruses from the mammalian central nervous system.

Authors:  B Dietzschold
Journal:  Trends Microbiol       Date:  1993-05       Impact factor: 17.079

6.  Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier.

Authors:  Isabelle St-Amour; Isabelle Paré; Wael Alata; Katherine Coulombe; Cassandra Ringuette-Goulet; Janelle Drouin-Ouellet; Milène Vandal; Denis Soulet; Renée Bazin; Frédéric Calon
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-18       Impact factor: 6.200

Review 7.  Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

8.  Macromolecular permeability across the blood-nerve and blood-brain barriers.

Authors:  J F Poduslo; G L Curran; C T Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 9.  Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.

Authors:  Luc Bertrand; Madhavan Nair; Michal Toborek
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 10.  Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Authors:  R Deane; R D Bell; A Sagare; B V Zlokovic
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.